Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome.

Pendred syndrome (PDS) is an autosomal recessive disorder characterized by deafness and goiter. Phenotypic heterogeneity is observed in affected individuals, and thyroid dysfunction is particularly variable. The syndrome is caused by mutations in the PDS (SLC26A4) gene, encoding an anion transporter pendrin, which localizes to the apical membrane of thyroid follicular cells. PDS is thought to enable efflux iodide into the follicle lumen. More than 50 diseases causing mutations of PDS have been reported. Here we have investigated the effect of nine PDS missense mutations on pendrin localization and iodide transport with the view to understanding their functional impact. As demonstrated by transient expression of green fluorescent protein-tagged pendrin mutant constructs in mammalian cell lines, appropriate trafficking to the plasma membrane was observed for only two mutants. The remaining PDS mutants appear to be retained within the endoplasmic reticulum following transfection. Iodide efflux assays were performed using human embryonic kidney 293 cells transfected with mutant pendrin and cotransfected with sodium iodide transporter to provide a mechanism of iodide uptake. The results indicated loss of pendrin iodide transport for all mislocalizing mutations. However, PDS mutants are associated with variable thyroid dysfunction in affected subjects. We concluded that additional genetic and/or environmental factors influence the thyroid activity in Pendred syndrome.

[1]  J. Perheentupa,et al.  Congenital chloride diarrhea. , 1982, Ergebnisse der inneren Medizin und Kinderheilkunde.

[2]  E. Green,et al.  A mutation in PDS causes non-syndromic recessive deafness , 1998, Nature Genetics.

[3]  V. Sheffield,et al.  Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype–phenotype correlations , 2001, Human mutation.

[4]  P. Kopp,et al.  Clinical and molecular analysis of three Mexican families with Pendred's syndrome. , 2001, European journal of endocrinology.

[5]  M. Ludgate,et al.  The modulation of the human sodium iodide symporter activity by Graves' disease sera. , 1998, The Journal of clinical endocrinology and metabolism.

[6]  X. Estivill,et al.  Splice‐site mutation in the PDS gene may result in intrafamilial variability for deafness in Pendred syndrome , 1999, Human mutation.

[7]  A S Verkman,et al.  Misfolding of Mutant Aquaporin-2 Water Channels in Nephrogenic Diabetes Insipidus* , 1999, The Journal of Biological Chemistry.

[8]  J. Kere,et al.  III. Congenital chloride diarrhea. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[9]  W. Reardon,et al.  Radiological malformations of the ear in Pendred syndrome. , 1998, Clinical radiology.

[10]  L. Maltais,et al.  Inherited primary hypothyroidism in mice. , 1981, Science.

[11]  C H Fox,et al.  The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. , 1996, Genes & development.

[12]  M. Pembrey,et al.  Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4 , 1996, Nature Genetics.

[13]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[14]  P. Kopp,et al.  Pendrin: an apical Cl-/OH-/HCO3- exchanger in the kidney cortex. , 2001, American journal of physiology. Renal physiology.

[15]  R. Beauwens,et al.  The iodide channel of the thyroid: a plasma membrane vesicle study. , 1992, The American journal of physiology.

[16]  V. Sheffield,et al.  Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification , 1996, Nature Genetics.

[17]  L. Ericson,et al.  Iodide transport in primary cultured thyroid follicle cells: evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. , 1990, European journal of cell biology.

[18]  E. Green,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Pendrin, the Protein Encoded by the Pendred Syndrome , 1999 .

[19]  W. Reardon,et al.  Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome , 1999, Journal of medical genetics.

[20]  T. Endo,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Detection of Binding and Blocking Autoantibodies to the Human Sodium-Iodide Symporter in Patients with , 2022 .

[21]  R. Reithmeier,et al.  Trafficking and Folding Defects in Hereditary Spherocytosis Mutants of the Human Red Cell Anion Exchanger , 2000, Traffic.

[22]  V. Lazar,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Expression of Pendrin and the Pendred Syndrome (PDS) , 2022 .

[23]  N. Philp,et al.  Effect of thyrotropin on iodide efflux in FRTL-5 cells mediated by Ca2+. , 1984, Endocrinology.

[24]  H. Schöler,et al.  A mouse model for hereditary thyroid dysgenesis and cleft palate , 1998, Nature Genetics.

[25]  W. Kimberling,et al.  Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations , 1999, Human Genetics.

[26]  E. Green,et al.  Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. , 2001, Human molecular genetics.

[27]  Jing Zheng,et al.  Prestin is the motor protein of cochlear outer hair cells , 2000, Nature.

[28]  J. Hardelin,et al.  Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation. , 2000, American journal of medical genetics.

[29]  E. Green,et al.  Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  V. Sheffield,et al.  Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). , 2000, Human molecular genetics.

[31]  W. Reardon,et al.  Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene. , 2000, QJM : monthly journal of the Association of Physicians.

[32]  G. Fraser,et al.  Association of congenital deafness with goitre (Pendred's syndrome): A study of 207 families , 1964, Annals of human genetics.

[33]  E. Green,et al.  Identification of two different mutations in the PDS gene in an inbred family with Pendred syndrome , 1999, Journal of medical genetics.

[34]  D. Scott,et al.  Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. , 2000, American journal of physiology. Cell physiology.

[35]  V. Pendred.  DEAF-MUTISM AND GOITRE. , 1896 .

[36]  Rong Wang,et al.  The Pendred syndrome gene encodes a chloride-iodide transport protein , 1999, Nature Genetics.

[37]  S. Scherer,et al.  Molecular analysis of the PDS gene in Pendred syndrome. , 1998, Human molecular genetics.

[38]  V. Sheffield,et al.  Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS) , 1997, Nature Genetics.

[39]  E. Green,et al.  A family of mammalian anion transporters and their involvement in human genetic diseases. , 1999, Human molecular genetics.

[40]  N. Carrasco,et al.  Molecular Study of the Sodium–Iodide Symporter (NIS): A New Field in Thyroidology , 2000, Trends in Endocrinology & Metabolism.

[41]  E. Green,et al.  Two frequent missense mutations in Pendred syndrome. , 1998, Human molecular genetics.